Clin Mol Hepatol.
2023 Feb;29(suppl):S5-S16. 10.3350/cmh.2022.0424.
Non-alcoholic fatty liver disease: Definition and subtypes
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
- 2Regenerative Medicine Research Center, Yonsei University Wonju College of Medicine, Wonju, Korea
- 3Cell Therapy and Tissue Engineering Center, Yonsei University Wonju College of Medicine, Wonju, Korea
- KMID: 2539786
- DOI: http://doi.org/10.3350/cmh.2022.0424
Abstract
- Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide, with a global prevalence of approximately 30%. However, the prevalence of NAFLD has been variously reported depending on the comorbidities. The rising prevalence of obesity in both the adult and pediatric populations is projected to consequently continue increasing NAFLD prevalence. It is a major cause of chronic liver disease worldwide, including cirrhosis and hepatocellular carcinoma (HCC). NAFLD has a variety of clinical phenotypes and heterogeneity due to the complexity of pathogenesis and clinical conditions of its occurrence, resulting in various clinical prognoses. In this article, we briefly described the basic definition of NAFLD and classified the subtypes based on current knowledge in this field.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
- Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
- Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
- How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
- A Case of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
